Latest News

In a 10-year study, U.S. adults reported growing rates of problems with their memory, concentration, and decision-making abilities, with the figure doubling among the youngest cohort.

The number of beds for neurocritical care patients will nearly quadruple when the Adams Neurosciences Center opens at the Saint Raphael Campus in 2027. The York Street Campus Neuro ICU will remain open, and the Neurosciences Center will have a 28-bed Neuro ICU. The Center will also have a 28-bed Neuro Intermediate Care Unit providing a stepped-down level of care. Currently Yale New Haven Hospital has just three neuro stepdown beds, with patients being cared for in other units.

Santiago Clocchiatti-Tuozzo, MD, MHS, a resident in the Department of Neurology, led a study that found that patients with atrial fibrillation who were prescribed Eliquis as an anticoagulant and carry the APOE e4 allele have an elevated risk of secondary stroke than those who are prescribed Coumadin, another anticoagulant.

For 15 years, Yale neurologist Kevin Sheth has been helping to lead a translational program in acute stroke treatment from the laboratory to human studies.

The Center for Medical Education has announced sixteen new fellows to participate in the Education Scholar Fellowship for 2025-2026.

Yale faculty, trainees, postdocs, and students will present research at the upcoming American Heart Association Scientific Sessions in Chicago later this month.

Associate Research Scientist Cyprien Rivier, MD, MSc, is one of two recipients of the Ralph L. Sacco Scholarship for Brain Health. This grant, awarded jointly by the American Heart Association and American Academy of Neurology, supports Rivier's current research into the effect of biological age on brain health.

Assistant Professor of Neurology Rachel Forman, MD, joins an expert panel to discuss the clinical and social elements that impact patient outcomes following an acute brain injury.

When it comes to stroke treatment, every minute counts. A new study identifies factors associated with treatment delays — and targets for intervention.